Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations

Zishuo I. Hu, Markku Miettinen, Martha Quezado, Alexandra P. Lebensohn, Kenneth Aldape, Maria Agra, Cathy Wagner, Yvonne Mallory, Raffit Hassan, Azam Ghafoor

Research output: Contribution to journalArticlepeer-review


BAP1 is a tumor suppressor gene implicated in DNA repair and cell growth. Individuals with germline BAP1 mutations are at a significantly increased risk for developing many different cancers including malignant mesothelioma, uveal melanomas, cutaneous melanomas and renal clear cell carcinomas. Meningiomas with absent BAP1 expression have been reported to be more aggressive and present often with rhabdoid features. Here, we report the co-occurrence of pleural mesotheliomas and meningiomas in patients with germline BAP1 mutations. We describe the cancer history, family pedigrees, clinical management, and outcomes of four BAP1 germline mutation carrier families with a history of malignant mesothelioma and meningioma.

Original languageEnglish
Pages (from-to)461-466
Number of pages6
JournalJournal of Thoracic Oncology
Issue number3
StatePublished - Mar 2022


  • BAP1
  • Germline
  • Meningioma
  • Mesothelioma


Dive into the research topics of 'Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations'. Together they form a unique fingerprint.

Cite this